Temat: "Neoplasm Recurrence, Local" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Efficacy of surgery in the management of multiple recurrences of retroperitoneal dedifferentiated liposarcoma.
Autorzy:: Yamada Y; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Wakamatsu T; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan. .; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan. .
Imura Y; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Tamiya H; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Yagi T; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.
Suzuki R; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Inoue A; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Takami H; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Nakai S; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Outani H; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Kakunaga S; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.
Takenaka S; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka, 565-0871, Japan.; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2024 Oct 05; Vol. 22 (1), pp. 265. Date of Electronic Publication: 2024 Oct 05.
Typ publikacji:: Journal Article
MeSH Terms:: Retroperitoneal Neoplasms*/surgery
Retroperitoneal Neoplasms*/pathology
Retroperitoneal Neoplasms*/mortality
Retroperitoneal Neoplasms*/diagnostic imaging
Neoplasm Recurrence, Local*/surgery
Neoplasm Recurrence, Local*/pathology
Liposarcoma*/surgery
Liposarcoma*/pathology
Liposarcoma*/mortality
Humans ; Male ; Female ; Aged ; Middle Aged ; Survival Rate ; Prognosis ; Follow-Up Studies ; Adult ; Retrospective Studies ; Aged, 80 and over ; Fluorodeoxyglucose F18 ; Positron-Emission Tomography/methods
SCR Disease Name:: Retroperitoneal liposarcoma

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 2.

Tytuł:: Proteogenomic Characterization of Early Intrahepatic Recurrence after Curative-Intent Treatment of Colorectal Liver Metastases.
Autorzy:: Wong GYM; Department of Upper Gastrointestinal Surgery, Royal North Shore Hospital, Sydney, New South Wales 2065, Australia.; Northern Clinical School, The University of Sydney, Sydney, New South Wales 2065, Australia.; Bowel Cancer and Biomarker Research Laboratory, Kolling Institute, St Leonards, New South Wales 2065, Australia.
Li J; Bowel Cancer and Biomarker Research Laboratory, Kolling Institute, St Leonards, New South Wales 2065, Australia.
McKay M; Bowel Cancer and Biomarker Research Laboratory, Kolling Institute, St Leonards, New South Wales 2065, Australia.
Castaneda M; Bowel Cancer and Biomarker Research Laboratory, Kolling Institute, St Leonards, New South Wales 2065, Australia.
Bhimani N; Department of Upper Gastrointestinal Surgery, Royal North Shore Hospital, Sydney, New South Wales 2065, Australia.; Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales 2050, Australia.
Diakos C; Northern Clinical School, The University of Sydney, Sydney, New South Wales 2065, Australia.; Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales 2065, Australia.
Hugh TJ; Department of Upper Gastrointestinal Surgery, Royal North Shore Hospital, Sydney, New South Wales 2065, Australia.; Northern Clinical School, The University of Sydney, Sydney, New South Wales 2065, Australia.
Molloy MP; Bowel Cancer and Biomarker Research Laboratory, Kolling Institute, St Leonards, New South Wales 2065, Australia.; Pokaż więcej
Źródło:: Journal of proteome research [J Proteome Res] 2024 Oct 04; Vol. 23 (10), pp. 4523-4537. Date of Electronic Publication: 2024 Sep 12.
Typ publikacji:: Journal Article
MeSH Terms:: Colorectal Neoplasms*/pathology
Colorectal Neoplasms*/genetics
Liver Neoplasms*/secondary
Liver Neoplasms*/genetics
Liver Neoplasms*/surgery
Proteogenomics*/methods
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/pathology
Biomarkers, Tumor*/genetics
Humans ; Male ; Female ; Middle Aged ; Prognosis ; Aged ; Mutation

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 3.

Tytuł:: Re-irradiation of anaplastic meningioma: higher dose and concomitant Bevacizumab may improve progression-free survival.
Autorzy:: Haisraely O; Sheba Medical Center, Tel Aviv Medical School, Tel Aviv University, Tel Aviv, Israel. .
Taliansky A; Sheba Medical Center, Tel Aviv Medical School, Tel Aviv University, Tel Aviv, Israel.
Sivan M; Sheba Medical Center, Tel Aviv Medical School, Tel Aviv University, Tel Aviv, Israel.
Lawerence Y; Sheba Medical Center, Tel Aviv Medical School, Tel Aviv University, Tel Aviv, Israel.; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2024 Oct 02; Vol. 19 (1), pp. 135. Date of Electronic Publication: 2024 Oct 02.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Meningioma*/radiotherapy
Meningioma*/pathology
Meningioma*/mortality
Bevacizumab*/therapeutic use
Meningeal Neoplasms*/radiotherapy
Meningeal Neoplasms*/pathology
Meningeal Neoplasms*/therapy
Re-Irradiation*/adverse effects
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/radiotherapy
Progression-Free Survival*
Humans ; Retrospective Studies ; Middle Aged ; Male ; Female ; Aged ; Adult ; Radiotherapy Dosage ; Aged, 80 and over ; Antineoplastic Agents, Immunological/therapeutic use ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Autorzy:: Suleiman R; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
McGarrah P; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Baral B; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Owen D; Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Vera Aguilera J; Division of Hematology/Oncology, Essentia Health, Duluth, Minnesota, USA.
Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Price KA; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Fuentes Bayne HE; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Pokaż więcej
Źródło:: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Oct; Vol. 7 (10), pp. e70023.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Squamous Cell Carcinoma of Head and Neck*/therapy
Squamous Cell Carcinoma of Head and Neck*/secondary
Squamous Cell Carcinoma of Head and Neck*/pathology
Squamous Cell Carcinoma of Head and Neck*/drug therapy
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/therapy
Antibodies, Monoclonal, Humanized*/therapeutic use
Antibodies, Monoclonal, Humanized*/administration & dosage
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Humans ; Female ; Aged ; Male ; Middle Aged ; Immunotherapy/methods ; Head and Neck Neoplasms/therapy ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/drug therapy ; Class I Phosphatidylinositol 3-Kinases/genetics ; Thiazoles

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 5.

Tytuł:: Fear of Cancer Recurrence in Adult Survivors of Childhood Cancer.
Autorzy:: Pizzo A; Department of Psychology, Concordia University, Montréal, Québec, Canada.
Leisenring WM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Stratton KL; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Lamoureux É; Department of Psychology, Concordia University, Montréal, Québec, Canada.
Flynn JS; Department of Psychology and Biobehavioral Sciences, St Jude Children's Research Hospital, Memphis, Tennessee.
Alschuler K; Department of Rehabilitation Medicine, University of Washington, Seattle.
Krull KR; Department of Psychology and Biobehavioral Sciences, St Jude Children's Research Hospital, Memphis, Tennessee.
Jibb LA; The Hospital for Sick Children, Toronto, Ontario, Canada.
Nathan PC; The Hospital for Sick Children, Toronto, Ontario, Canada.
Olgin JE; Department of Medicine, University of California, San Francisco.
Stinson JN; The Hospital for Sick Children, Toronto, Ontario, Canada.
Armstrong GT; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee.
Alberts NM; Department of Psychology, Concordia University, Montréal, Québec, Canada.; Pokaż więcej
Źródło:: JAMA network open [JAMA Netw Open] 2024 Oct 01; Vol. 7 (10), pp. e2436144. Date of Electronic Publication: 2024 Oct 01.
Typ publikacji:: Journal Article
MeSH Terms:: Cancer Survivors*/psychology
Cancer Survivors*/statistics & numerical data
Fear*/psychology
Neoplasm Recurrence, Local*/psychology
Neoplasm Recurrence, Local*/epidemiology
Humans ; Female ; Male ; Adult ; Cross-Sectional Studies ; Retrospective Studies ; Neoplasms/psychology ; Neoplasms/epidemiology ; Risk Factors ; Middle Aged ; Prevalence ; Child

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 6.

Tytuł:: Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.
Autorzy:: Fine RE; Margaret West Comprehensive Breast Center, West Cancer Center and Research Institute, Germantown, TN, USA. .
Gilmore RC; Margaret West Comprehensive Breast Center, West Cancer Center and Research Institute, Germantown, TN, USA.
Tomkovich KR; CentraState Medical Center, Freehold, NJ, USA.
Dietz JR; University Hospital Cleveland Medical Center, Cleveland, OH, USA.; Cleveland, OH, USA.
Berry MP; Margaret West Comprehensive Breast Center, West Cancer Center and Research Institute, Germantown, TN, USA.
Hernandez LE; Cincinnati Breast Surgeons Inc, Cincinnati, OH, USA.
Columbus KS; Cincinnati Breast Surgeons Inc, Cincinnati, OH, USA.
Seedman SA; Presbyterian Cancer Center, Rio Rancho, NM, USA.
Fisher CS; Indiana University IU Health Hospital-University Hospital, Indianapolis, IN, USA.
Han LK; Indiana University IU Health Hospital-University Hospital, Indianapolis, IN, USA.
Manahan ER; Dalton Surgical Group, Dalton, GA, USA.
Hicks RD; Regional Medical Imaging, Flint, MI, USA.
Vaidya RP; Ironwood Cancer and Research Centers, Glendale, AZ, USA.
Curcio LD; BreastLink Laguna Hills, Laguna Hills, CA, USA.
Sevrukov AB; Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Kenler AS; Bridgeport Hospital, Bridgeport, CT, USA.
Taback B; Columbia University Medical Center, New York, NY, USA.
Chen M; Columbia University Medical Center, New York, NY, USA.
Miller ME; University Hospital Cleveland Medical Center, Cleveland, OH, USA.
Gold L; Comprehensive Breast Care, Troy, MI, USA.
Anglin BV; Complete Breast Care, Plano, TX, USA.
Aoun HD; Karmanos Cancer Institute, Detroit, MI, USA.
Simmons RM; Weill Cornell Weill Medical College, Cornell University, New York, NY, USA.
Feldman SM; Montefiore-Einstein Center for Cancer Care, New York, NY, USA.
Boolbol SK; Mount Sinai Beth Israel, New York, NY, USA.; Nuvance Health System, Poughkeepsie, NY, USA.; Pokaż więcej
Źródło:: Annals of surgical oncology [Ann Surg Oncol] 2024 Oct; Vol. 31 (11), pp. 7273-7283. Date of Electronic Publication: 2024 Sep 16.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Breast Neoplasms*/pathology
Breast Neoplasms*/surgery
Cryosurgery*/methods
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Carcinoma, Ductal, Breast*/surgery
Carcinoma, Ductal, Breast*/pathology
Neoplasm Staging*
Humans ; Female ; Aged ; Middle Aged ; Follow-Up Studies ; Prospective Studies ; Aged, 80 and over ; Survival Rate ; Prognosis ; Neoplasm Grading ; Receptor, ErbB-2/metabolism

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 7.

Tytuł:: Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial.
Autorzy:: Peng Z; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li H; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Gao Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gynaecological Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Sun L; Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Jiang J; Department of Obstetrics and Gynaecology, Qilu Hospital, Shandong University, Jinan, China.
Xia B; Department of Gynaecology Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Huang Y; Department of Gynaecological Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Y; Department of Gynaecology, Xiangya Hospital, Central South University, Changsha, China.
Xia Y; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Y; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shen Y; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Huang B; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Nie J; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen X; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu X; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Feng C; Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li Z; Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang W; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tao K; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Q; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Duan S; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen Y; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen Y; Department of Gynaecological Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gynaecological Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Zheng H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gynaecological Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Lu Y; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu Y; Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Wang L; Department of Obstetrics and Gynaecology, Qilu Hospital, Shandong University, Jinan, China.
Qi W; Department of Gynaecology Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
He Y; Department of Gynaecological Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tian Y; Department of Gynaecology, Xiangya Hospital, Central South University, Changsha, China.
Li G; Department of Gynaecological Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ma D; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Gao Q; Department of Obstetrics and Gynaecology, National Clinical Research Centre for Obstetrics and Gynaecology, Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumour Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: .; Pokaż więcej
Corporate Authors:: NUWA Platform Research Group
Źródło:: The Lancet. Oncology [Lancet Oncol] 2024 Oct; Vol. 25 (10), pp. 1288-1297. Date of Electronic Publication: 2024 Sep 11.
Typ publikacji:: Journal Article; Clinical Trial, Phase II; Multicenter Study
MeSH Terms:: Bevacizumab*/administration & dosage
Bevacizumab*/adverse effects
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/pathology
Antibodies, Monoclonal, Humanized*/adverse effects
Antibodies, Monoclonal, Humanized*/therapeutic use
Antibodies, Monoclonal, Humanized*/administration & dosage
Humans ; Female ; Middle Aged ; Adult ; Aged ; Prospective Studies ; Adenocarcinoma, Clear Cell/drug therapy ; Adenocarcinoma, Clear Cell/pathology ; Young Adult ; Carcinoma, Ovarian Epithelial/drug therapy ; Adolescent ; China

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 8.

Tytuł:: ASO Author Reflections: Postoperative Peritoneal Dissemination Recurrence of Pleural Mesothelioma has a Poor Prognosis.
Autorzy:: Nakamura A; Division of Thoracic Surgery, Department of Surgery, Hyogo Medical University, Nishinomiya, Hyogo, Japan. .
Hashimoto M; Division of Thoracic Surgery, Department of Surgery, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
Funaki S; Division of Thoracic Surgery, Department of Surgery, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
Hasegawa S; Division of Thoracic Surgery, Department of Surgery, Hyogo Medical University, Nishinomiya, Hyogo, Japan.; Department of Thoracic Surgery, Takarazuka City Hospital, Takarazuka, Hyogo, Japan.; Pokaż więcej
Źródło:: Annals of surgical oncology [Ann Surg Oncol] 2024 Oct; Vol. 31 (10), pp. 6729-6730. Date of Electronic Publication: 2024 Aug 29.
Typ publikacji:: Journal Article
MeSH Terms:: Peritoneal Neoplasms*/secondary
Peritoneal Neoplasms*/surgery
Pleural Neoplasms*/pathology
Pleural Neoplasms*/surgery
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Mesothelioma*/pathology
Mesothelioma*/surgery
Humans ; Prognosis ; Survival Rate ; Mesothelioma, Malignant/pathology ; Mesothelioma, Malignant/surgery ; Lung Neoplasms/surgery ; Lung Neoplasms/pathology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 9.

Tytuł:: Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer.
Autorzy:: Chen L; Oxford Population Health, Richard Doll Building, Old Road Campus, University of Oxford, Oxford, OX3 7LF, UK.
McIntosh SA; The Patrick G Johnston Centre for Cancer Research, Queen's University, Belfast, BT9 7AE, UK.
Tyagi S; King's Mill Hospital, Mansfield Rd, Sutton-in-Ashfield, NG17 4JL, UK.
Dodwell D; Oxford Population Health, Richard Doll Building, Old Road Campus, University of Oxford, Oxford, OX3 7LF, UK. Electronic address: .; Pokaż więcej
Źródło:: Breast (Edinburgh, Scotland) [Breast] 2024 Oct; Vol. 77, pp. 103791. Date of Electronic Publication: 2024 Aug 27.
Typ publikacji:: Journal Article; Systematic Review
MeSH Terms:: Breast Neoplasms*/therapy
Breast Neoplasms*/pathology
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/prevention & control
Adult ; Female ; Humans

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 10.

Tytuł:: Exploring metastasis and recurrence patterns in low-risk grade 3 endometrial cancer: A multicenter retrospective cohort study.
Autorzy:: Aiob A; Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Lee KB; Department of Obstetrics and Gynecology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
Kim SI; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim NK; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Kang S; Center for Gynecologic Cancer, National Cancer Center, Goyang, Republic of Korea.
Lee CH; Department of Obstetrics and Gynecology, Graduate School of Medicine, Dongguk University, Seoul, Republic of Korea.
Jeong DH; Department of Obstetrics & Gynecology, Busan Paik Hospital, Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea.
Lee B; Department of Obstetrics and Gynecology, Inha University Hospital, Inha University College of Medicine, Incheon, Republic of Korea.
Kim K; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. Electronic address: .; Pokaż więcej
Źródło:: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Oct; Vol. 301, pp. 154-159. Date of Electronic Publication: 2024 Aug 12.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Endometrial Neoplasms*/pathology
Endometrial Neoplasms*/mortality
Endometrial Neoplasms*/surgery
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/epidemiology
Lymphatic Metastasis*
Humans ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Neoplasm Grading ; Lymph Node Excision ; Prognosis ; Adult ; Hysterectomy ; Carcinoma, Endometrioid/pathology ; Carcinoma, Endometrioid/mortality ; Carcinoma, Endometrioid/surgery ; Carcinoma, Endometrioid/therapy

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 11.

Tytuł:: Repeat endoscopic submucosal dissection close to the initial endoscopic submucosal dissection scar for superficial esophageal squamous cell carcinoma.
Autorzy:: Matsuoka K; Department of Gastroenterology, Akashi Medical Center, 743-33 Yagi Okubo-Cho, Akashi, Hyogo, 747-0063, Japan.
Ishida T; Department of Gastroenterology, Akashi Medical Center, 743-33 Yagi Okubo-Cho, Akashi, Hyogo, 747-0063, Japan. .
Yoshizaki T; Division of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
Yamamoto Y; Department of Gastrointestinal Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan.
Iwatate M; Department of Gastroenterology, Sano Hospital, Kobe, Hyogo, Japan.
Kitamura Y; Department of Gastroenterology, Yodogawa Christian Hospital, Osaka, Japan.
Sako T; Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
Ikeda A; Department of Gastroenterology, Sanda City Hospital, Sanda, Hyogo, Japan.
Ose T; Department of Gastroenterology, Kita-Harima Medical Center, Ono, Hyogo, Japan.
Kawara F; Department of Gastroenterology, Konan Medical Center, Kobe, Hyogo, Japan.
Ariyoshi R; Department of Gastroenterology, Hyogo Prefectural Harima-Himeji General Medical Center, Himeji, Hyogo, Japan.
Sano Y; Department of Gastroenterology, Sano Hospital, Kobe, Hyogo, Japan.
Abe H; Division of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
Tanaka S; Tanaka Clinic of Internal Medicine, Kobe, Hyogo, Japan.
Takao T; Division of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
Morita Y; Division of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
Toyonaga T; Division of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
Shimokawa T; Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan.
Kodama Y; Division of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.; Pokaż więcej
Źródło:: Esophagus : official journal of the Japan Esophageal Society [Esophagus] 2024 Oct; Vol. 21 (4), pp. 505-513. Date of Electronic Publication: 2024 Jul 27.
Typ publikacji:: Journal Article; Evaluation Study
MeSH Terms:: Endoscopic Mucosal Resection*/methods
Endoscopic Mucosal Resection*/adverse effects
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/surgery
Esophageal Neoplasms*/pathology
Neoplasm Recurrence, Local*/surgery
Neoplasm Recurrence, Local*/epidemiology
Cicatrix*/etiology
Propensity Score*
Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Reoperation/statistics & numerical data ; Reoperation/methods ; Retrospective Studies ; Esophagoscopy/methods ; Esophagoscopy/adverse effects ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Kaplan-Meier Estimate

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 12.

Tytuł:: Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease after first-line chemotherapy: An ad hoc subgroup analysis of PRIMA/ENGOT-OV26/GOG-3012.
Autorzy:: Kamrava MR; Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: .
Gonzalez-Martin A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO) and Cancer Clínica Universidad de Navarra, Madrid, Spain.
Pothuri B; NYU Langone Health Perlmutter Cancer Center, New York, NY, USA.
Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Graybill W; Gynecologic Oncology Group (GOG) and Medical University of South Carolina, Charleston, SC, USA.
Mirza MR; Nordic Society of Gynecologic Oncology (NSGO) and Rigshositalet-Copenhagen University Hospital, Copenhagen, Denmark.
McCormick C; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Lorusso D; Director of Gynecologic Oncology Unit Humanitas San Pio X Milan and Full Professor of Obstetrics and Gynecology Humanitas University Rozzano (MI), Milan, Italy.
Freyer G; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens and Centre Hospitalier Lyon-Sud, Lyon, France.
O'Malley DM; The Ohio State University and The James Comprehensive Cancer Center, Columbus, OH, USA.
York W; GSK, Philadelphia, PA, USA.
Malinowska IA; GSK, Philadelphia, PA, USA.
Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA.; Pokaż więcej
Źródło:: Gynecologic oncology [Gynecol Oncol] 2024 Oct; Vol. 189, pp. 68-74. Date of Electronic Publication: 2024 Jul 19.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
MeSH Terms:: Indazoles*/administration & dosage
Indazoles*/therapeutic use
Piperidines*/administration & dosage
Piperidines*/therapeutic use
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/pathology
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Poly(ADP-ribose) Polymerase Inhibitors*/administration & dosage
Maintenance Chemotherapy*/methods
Humans ; Female ; Middle Aged ; Aged ; Adult ; Phthalazines/administration & dosage ; Phthalazines/adverse effects ; Phthalazines/therapeutic use ; Disease Progression

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 13.

Tytuł:: The mode of circumferential margin involvement in rectal cancer determines its impact on outcomes: A population-based study.
Autorzy:: Hugen N; Rijnstate, Department of Surgery, Arnhem, the Netherlands; Radboud University Medical Center, Department of Surgery, Nijmegen, the Netherlands. Electronic address: .
Voorham QJM; PALGA Foundation, Houten, the Netherlands.
Beets GL; Netherlands Cancer Institute, Department of Surgery, Amsterdam, the Netherlands.
Loughrey MB; Royal Victoria Hospital, Belfast Health and Social Care Trust, Department of Cellular Pathology, Belfast, UK; Queen's University Belfast, Belfast, UK.
Snaebjornsson P; Netherlands Cancer Institute, Department of Pathology, Amsterdam, the Netherlands; University of Iceland, Faculty of Medicine, Reykjavik, Iceland.
Nagtegaal ID; Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands.; Pokaż więcej
Źródło:: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Oct; Vol. 50 (10), pp. 108598. Date of Electronic Publication: 2024 Aug 14.
Typ publikacji:: Journal Article
MeSH Terms:: Rectal Neoplasms*/pathology
Rectal Neoplasms*/surgery
Margins of Excision*
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/pathology
Neoplasm Invasiveness*
Lymphatic Metastasis*
Neoplasm Staging*
Humans ; Female ; Male ; Aged ; Middle Aged ; Netherlands/epidemiology ; Survival Rate ; Adult ; Proctectomy ; Aged, 80 and over

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 14.

Tytuł:: Predicting Prognosis of Phyllodes Tumors Using a Mammography- and Magnetic Resonance Imaging-Based Radiomics Model: A Preliminary Study.
Autorzy:: Ma X; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang L; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Xiao Q; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Huang Y; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Lin L; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Peng W; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Gong J; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: .
Gu Y; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: .; Pokaż więcej
Źródło:: Clinical breast cancer [Clin Breast Cancer] 2024 Oct; Vol. 24 (7), pp. e571-e582.e1. Date of Electronic Publication: 2024 May 15.
Typ publikacji:: Journal Article
MeSH Terms:: Phyllodes Tumor*/diagnostic imaging
Phyllodes Tumor*/pathology
Phyllodes Tumor*/surgery
Phyllodes Tumor*/mortality
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Breast Neoplasms*/mortality
Magnetic Resonance Imaging*/methods
Mammography*/methods
Neoplasm Recurrence, Local*/diagnostic imaging
Neoplasm Recurrence, Local*/pathology
Humans ; Female ; Adult ; Retrospective Studies ; Prognosis ; Middle Aged ; Disease-Free Survival ; ROC Curve ; Young Adult ; Radiomics

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 15.

Tytuł:: Incidence of local breast cancer recurrence with delayed radiation therapy.
Autorzy:: Alabedi HH; Surgery Department, College of Medicine, Baghdad University, Baghdad, Iraq. .; College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq. .; Al-Warith Cancer Institute, Karbala, Iraq. .
Ahmed IK; Oncology and Nuclear Medicine Specialized Hospital, Ninava Directorate Health, Mosul, Iraq.
Jamil ASM; Oncology and Nuclear Medicine Specialized Hospital, Ninava Directorate Health, Mosul, Iraq.; Pokaż więcej
Źródło:: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Oct; Vol. 207 (3), pp. 625-631. Date of Electronic Publication: 2024 Jun 14.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/pathology
Breast Neoplasms*/pathology
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/epidemiology
Humans ; Female ; Middle Aged ; Adult ; Aged ; Retrospective Studies ; Incidence ; Mastectomy ; Time-to-Treatment ; Neoplasm Staging

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 16.

Tytuł:: Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged ≥90 Years: A Large Retrospective Cohort Study.
Autorzy:: Ferrucci M; Breast Surgery Unit, Veneto Institute of Oncology IOV, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy. .
Passeri D; General Surgery, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Milardi F; General Surgery, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Francavilla A; Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiothoracic Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Cagol M; Breast Surgery Unit, Veneto Institute of Oncology IOV, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy.
Toffanin M; Breast Surgery Unit, Veneto Institute of Oncology IOV, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy.
Montagna G; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marchet A; Breast Surgery Unit, Veneto Institute of Oncology IOV, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy.; Pokaż więcej
Źródło:: Annals of surgical oncology [Ann Surg Oncol] 2024 Oct; Vol. 31 (11), pp. 7377-7391. Date of Electronic Publication: 2024 Aug 04.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Breast Neoplasms*/mortality
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Mastectomy*/mortality
Humans ; Female ; Retrospective Studies ; Aged, 80 and over ; Survival Rate ; Follow-Up Studies ; Prognosis ; Carcinoma, Ductal, Breast/surgery ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Ductal, Breast/mortality

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 17.

Tytuł:: Radioactive iodine ablation therapy reduces the risk of recurrent disease in pediatric differentiated thyroid carcinoma.
Autorzy:: Toraih E; Division of Endocrine and Oncologic Surgery, Department of Surgery, School of Medicine, Tulane University, New Orleans, LA, 70112, USA; Genetics Unit, Department of Histology and Cell Biology, Faculty of Medicine, Suez Canal University, Ismailia, 41522, Egypt. Electronic address: .
Webster A; School of Medicine, Tulane University, New Orleans, LA, 70112, USA.
Pineda E; School of Medicine, Tulane University, New Orleans, LA, 70112, USA.
Pinion D; School of Medicine, Tulane University, New Orleans, LA, 70112, USA.
Baer L; School of Medicine, Tulane University, New Orleans, LA, 70112, USA.
Persons E; School of Medicine, Tulane University, New Orleans, LA, 70112, USA.
Herrera M; School of Medicine, Tulane University, New Orleans, LA, 70112, USA.
Hussein M; Division of Endocrine and Oncologic Surgery, Department of Surgery, School of Medicine, Tulane University, New Orleans, LA, 70112, USA; Ochsner Clinic Foundation, New Orleans, LA, 70121, USA.
Kandil E; Division of Endocrine and Oncologic Surgery, Department of Surgery, School of Medicine, Tulane University, New Orleans, LA, 70112, USA. Electronic address: .; Pokaż więcej
Źródło:: Surgical oncology [Surg Oncol] 2024 Oct; Vol. 56, pp. 102120. Date of Electronic Publication: 2024 Aug 08.
Typ publikacji:: Journal Article; Systematic Review; Meta-Analysis
MeSH Terms:: Iodine Radioisotopes*/administration & dosage
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/prevention & control
Thyroid Neoplasms*/epidemiology
Thyroid Neoplasms*/pathology
Thyroid Neoplasms*/radiotherapy
Thyroid Neoplasms*/surgery
Thyroidectomy*
Adolescent ; Child ; Female ; Humans ; Male ; Prognosis ; Young Adult

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 18.

Tytuł:: Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS).
Autorzy:: Casasanta N; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: .
Patel R; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.
Raymond S; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.
Kier MW; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.
Blanter J; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.
Sohval S; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Hovstadius M; Frank H. Netter School of Medicine at Quinnipiac University, Department of Medicine, Hamden, CT.
Wu C; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Zimmerman B; Department of Medicine, Division of Hematology and Medical Oncology, Northwell Cancer Institute, Riverhead, NY.
Cascetta K; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.
Bagiella E; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.
Tiersten A; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.; Pokaż więcej
Źródło:: Clinical breast cancer [Clin Breast Cancer] 2024 Oct; Vol. 24 (7), pp. 585-596. Date of Electronic Publication: 2024 Jun 12.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Breast Neoplasms*/therapy
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/pathology
Humans ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Chemotherapy, Adjuvant ; Gene Expression Profiling ; Aged ; Prognosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Antineoplastic Agents, Hormonal/therapeutic use ; Receptors, Estrogen/metabolism ; Risk Assessment/methods

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 19.

Tytuł:: Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma.
Autorzy:: Pereyra D; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Mandorfer M; Department of Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, General Hospital, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, General Hospital, Vienna, Austria.
Santol J; Department of Surgery, HPB Center Vienna Health Network and Sigmund Freud Private University, Vienna, Austria.; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Gregory L; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Koeditz C; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Ortmayr G; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Schuetz C; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Rumpf B; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Ammon D; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Laengle J; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Schwarz C; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Jonas JP; Department of Surgery, HPB Center Vienna Health Network and Sigmund Freud Private University, Vienna, Austria.
Pinter M; Department of Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, General Hospital, Vienna, Austria.
Lindenlaub F; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, General Hospital, Vienna, Austria.
Tamandl D; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, General Hospital, Vienna, Austria.
Thiels C; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Warner S; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Smoot R; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Truty M; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Kendrick M; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Nagorney D; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Cleary S; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Gruenberger T; Department of Surgery, HPB Center Vienna Health Network and Sigmund Freud Private University, Vienna, Austria.
Reiberger T; Department of Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, General Hospital, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, General Hospital, Vienna, Austria.; Christian-Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.
Starlinger P; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital, Vienna, Austria. .; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA. .; Pokaż więcej
Źródło:: Annals of surgical oncology [Ann Surg Oncol] 2024 Oct; Vol. 31 (10), pp. 6526-6536. Date of Electronic Publication: 2024 Jun 19.
Typ publikacji:: Journal Article
MeSH Terms:: Liver Neoplasms*/surgery
Liver Neoplasms*/blood
Liver Neoplasms*/pathology
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/blood
Carcinoma, Hepatocellular*/pathology
von Willebrand Factor*/metabolism
von Willebrand Factor*/analysis
Hepatectomy*
Biomarkers, Tumor*/blood
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/diagnosis
Humans ; Male ; Female ; Middle Aged ; Prospective Studies ; Survival Rate ; Follow-Up Studies ; Risk Assessment ; Prognosis ; Aged ; Hypertension, Portal ; ROC Curve

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 20.

Tytuł:: Extreme Oncoplasty: Oncologically Safe When Compared with Mastectomy.
Autorzy:: Hossino D; Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA. .; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. .
Silverstein MJ; Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Savalia N; Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Jayich M; Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Khan S; Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Pokaż więcej
Źródło:: Annals of surgical oncology [Ann Surg Oncol] 2024 Oct; Vol. 31 (11), pp. 7284-7288. Date of Electronic Publication: 2024 Jul 13.
Typ publikacji:: Journal Article; Comparative Study
MeSH Terms:: Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Breast Neoplasms*/radiotherapy
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Mastectomy, Segmental*
Mastectomy*
Humans ; Female ; Middle Aged ; Prospective Studies ; Survival Rate ; Follow-Up Studies ; Mammaplasty/methods ; Aged ; Prognosis ; Adult ; Radiotherapy, Adjuvant

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Informacja

Wyszukujesz frazę ""Neoplasm Recurrence, Local"" wg kryterium: Temat